Back to search

Article

Elevated TRAF6 expression confers radioresistance and predicts poor prognosis in cervical cancer

2026-07-13

Abstract excerpt

<h4>Background</h4> The lack of effective biomarkers and therapeutic targets to overcome radioresistance in cervical cancer remains a major clinical challenge. Tumor necrosis factor receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase pivotal in immune and inflammatory signaling, has been implicated in various malignancies. However, its role in radioresistance in cervical cancer remains unclear. <h4>Metho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fb35ce26-c935-54dd-b4ba-09c2dad25666
DOI
10.64898/2026.07.09.26357625
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Elevated TRAF6 expression confers radioresistance and predicts poor prognosis in cervical cancerDOI 10.64898/2026.07.09.26357625
The TFRC as a prognostic biomarker and potential therapeutic target in cervical cancer: a preliminary studySemantic proximity
Single‐cell transcriptomic analysis of the role of HPV16‐positive macrophages in cervical cancer prognosisSemantic proximity
Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancerSemantic proximity
Molecular Differences between Squamous Cell Carcinoma and Adenocarcinoma Cervical Cancer Subtypes: Potential Prognostic BiomarkersSemantic proximity
miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6.Semantic proximity
Transcriptomic Profiling Reveals Predictive Markers of Response to Concurrent Chemoradiotherapy plus Immune Checkpoint Inhibition in Cervical CancerSemantic proximity
Identification of HPV16 positive cervical cancer subsets characterized by divergent immune and oncogenic phenotypes with potential implications for immunotherapy.Semantic proximity
Sequential gene expression analysis of cervical malignant transformation identifies RFC4 as a novel diagnostic and prognostic biomarkerSemantic proximity
TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma.Semantic proximity
Gene Expression Analysis Identifies Novel Targets for Cervical Cancer TherapySemantic proximity
Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancerSemantic proximity
PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancerSemantic proximity
Select a neighboring publication to make it the new centre.